Caplight Directory>Investors>4Bio Capital>4bio-capital


4Bio Capital

4Bio Capital

London, England4biocapital.com

Overview

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO's objective is to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.

Year Founded

2014

AUM

$167.3M

Portfolio Companies

14

Investments

CompanyDateStageLead
Cytospire TherapeuticsMay 2026Series ALead
Ray TherapeuticsApr 2026Series BCo-investor
TrogenixOct 2025Series ACo-investor
ActitheraJul 2025Series ALead
NV TherapeuticsMar 2025SeedLead
View all investments

Key People

Dima Kuzmin

Managing Partner

Brian McVeigh

Venture Partner

Tay Salimullah

Venture Partner

Natalie Johnston

Principal

Kieran Mudryy

Partner, General Counsel

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2014
AUM$167.3M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.